Skip to main content
. 2013 Nov 15;6(12):2800–2812.

Table 1.

Clinicopathologic characteristics of patients including the result of EGFR mutation testing

Characteristics All patients Patients with EGFR mutation Patients with EGFR wild type
Subjects 273 29 (10.6%) 244 (89.4%)
Sex
Male 151 (55.3%) 7 (24.2%) 144 (59%)
Female 122 (44.7%) 22 (75.8%) 100 (41%)
Age (years; range) 61.5 (25-84) 63.5 (40-77) 61.2 (25-84)
Male 61.9 (25-84) 62.9 (53-77) 61.9 (25-84)
Female 60.9 (37-82) 63.8 (40-77) 60.3 (37-82)
Type of material
Histological 189 (69.2%) 18 (62.1%) 171 (70.1%)
Cytological 84 (30.8%) 11 (37.9%) 73 (29.9%)
[fixed/fresh] [72 (26.4%)/12 (4.4%)] [8 (27.6%)/3 (10.3%)] [64 (26.2%)/9 (3.7%)]
Histological type
Adenocarcinoma 186 (68.1%) 26 (89.8%) 160 (65.6%)
Squamous cell carcinoma 44 (16.1%) 2 (6.8%) 42 (17.2%)
Adenosquamous 4 (1.5%) 0 4 (1.6%)
Large cell carcinoma 9 (3.3%) 0 9 (3.7%)
NSCLC, NOS* 30 (11%) 1 (3.4%) 29 (11.9%)
EGFR gene copy number# 110 6 104
FISH positive 33 (30%) 4 (66.6%) 29 (27.8%)
FISH negative 77 (70%) 2 (33.4%) 75 (72.2%)
*

Not-otherwise specified.

#

Available only for histological samples.